TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Bio Vitos Pharma AB
Closing information (x1000 EUR)
| Closing information | 2022/12 | 2021/12 | 2020/12 |
| Turnover |
119
|
110
|
31 |
| Financial expenses |
0
|
0
|
3 |
| Earnings before taxes |
-1,339
|
-1,364
|
-1,165 |
| EBITDA |
-699
|
-737
|
-600 |
| Total assets |
2,377
|
3,471
|
3,565 |
| Current assets |
469
|
1,085
|
826 |
| Current liabilities |
137
|
192
|
225 |
| Equity capital |
2,240
|
3,279
|
3,340 |
| - share capital |
278
|
170
|
97 |
| Employees (average) |
5
|
6
|
5 |
Financial ratios
| Fiscal year | 2022/12 | 2021/12 | 2020/12 |
| Solvency |
94.2%
|
94.5%
|
93.7% |
| Turnover per employee |
24
|
18
|
6 |
| Profit as a percentage of turnover |
-1125.2%
|
-1240.0%
|
-3758.1% |
| Return on assets (ROA) |
-56.3%
|
-39.3%
|
-32.6% |
| Current ratio |
342.3%
|
565.1%
|
367.1% |
| Return on equity (ROE) |
-59.8%
|
-41.6%
|
-34.9% |
| Change turnover |
18
|
80
|
31 |
| Change turnover % |
18%
|
265% | |
| Chg. No. of employees |
-1
|
1
|
-2 |
| Chg. No. of employees % |
-17%
|
20%
|
-29% |
Total value of public sale
| Fiscal year | 2022/12 | 2021/12 | 2020/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.